These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 23181716)
1. Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas. Kostianets O; Antoniuk S; Filonenko V; Kiyamova R Diagn Pathol; 2012 Nov; 7():161. PubMed ID: 23181716 [TBL] [Abstract][Full Text] [Related]
2. Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades. Dyachenko L; Havrysh K; Lytovchenko A; Dosenko I; Antoniuk S; Filonenko V; Kiyamova R Dis Markers; 2016; 2016():5128720. PubMed ID: 27847402 [No Abstract] [Full Text] [Related]
3. Usefulness and limitations of E-cadherin and β-catenin in the classification of breast carcinomas in situ with mixed pattern. Gomes DS; Porto SS; Rocha RM; Gobbi H Diagn Pathol; 2013 Jul; 8():114. PubMed ID: 23837653 [TBL] [Abstract][Full Text] [Related]
4. [Expression of the adhesion molecule CD44v6 in infiltrating ductal carcinomas of the breast is associated with hormone dependence. Our experience with 168 cases]. Ruibal A; Schneider J; del Río MC; Arias J; Núñez MI; Tejerina A Rev Esp Med Nucl; 2000 Sep; 19(5):350-5. PubMed ID: 11062111 [TBL] [Abstract][Full Text] [Related]
5. [Expression of CD44 variant v6 in breast carcinoma and its relationship with other parameters of tumor biology]. Aceituno E; Turrión F; San Román JM; Sarasa JL; Ortiz F; García R Med Clin (Barc); 1998 Jul; 111(5):168-71. PubMed ID: 9732832 [TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of estrogen/progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin. Wallace ML; Smoller BR Am J Dermatopathol; 1996 Jun; 18(3):241-7. PubMed ID: 8806958 [TBL] [Abstract][Full Text] [Related]
7. High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack? Hofman P; Hsi BL; Manie S; Fenichel P; Thyss A; Rossi B Breast Cancer Res Treat; 1994; 32(2):213-9. PubMed ID: 7532466 [TBL] [Abstract][Full Text] [Related]
8. Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer. Won HS; Lee KE; Sung SH; Choi MY; Jo JY; Nam EM; Mun YC; Seong CM; Lee SN Tumori; 2014; 100(1):80-6. PubMed ID: 24675496 [TBL] [Abstract][Full Text] [Related]
9. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer. Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458 [TBL] [Abstract][Full Text] [Related]
10. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory receptor immunoglobulin-like transcript 4 was highly expressed in primary ductal and lobular breast cancer and significantly correlated with IL-10. Liu J; Wang L; Gao W; Li L; Cui X; Yang H; Lin W; Dang Q; Zhang N; Sun Y Diagn Pathol; 2014 Apr; 9():85. PubMed ID: 24762057 [TBL] [Abstract][Full Text] [Related]
12. Expression of metalloproteases and their inhibitors in different histological types of breast cancer. Del Casar JM; González-Reyes S; González LO; González JM; Junquera S; Bongera M; García MF; Andicoechea A; Serra C; Vizoso FJ J Cancer Res Clin Oncol; 2010 Jun; 136(6):811-9. PubMed ID: 19916023 [TBL] [Abstract][Full Text] [Related]
13. The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas. Xu X; Jin H; Liu Y; Liu L; Wu Q; Guo Y; Yu L; Liu Z; Zhang T; Zhang X; Dong X; Quan C Diagn Pathol; 2012 Mar; 7():33. PubMed ID: 22455563 [TBL] [Abstract][Full Text] [Related]
14. Expression of epitopes of the tumour-associated glycoprotein 72 and clinicopathological correlations in mammary carcinomas. Contegiacomo A; Alimandi M; Muraro R; Pizzi C; Calderopoli R; De Marchis L; Sgambato A; Pettinato G; Petrella G; De Filippo MR Eur J Cancer; 1994; 30A(6):813-20. PubMed ID: 7522495 [TBL] [Abstract][Full Text] [Related]
15. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Dall P; Heider KH; Sinn HP; Skroch-Angel P; Adolf G; Kaufmann M; Herrlich P; Ponta H Int J Cancer; 1995 Feb; 60(4):471-7. PubMed ID: 7530237 [TBL] [Abstract][Full Text] [Related]
16. Cell proliferation in breast carcinoma assessed by a PCNA grading system and its relation to other prognostic variables. Betta PG; Bottero G; Pavesi M; Pastormerlo M; Bellinger D; Tallarida F Surg Oncol; 1993; 2(1):59-63. PubMed ID: 7902763 [TBL] [Abstract][Full Text] [Related]
17. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions. Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376 [TBL] [Abstract][Full Text] [Related]
18. Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas. Turashvili G; Bouchal J; Ehrmann J; Fridman E; Skarda J; Kolar Z Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Jun; 151(1):59-64. PubMed ID: 17690741 [TBL] [Abstract][Full Text] [Related]
19. Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas. Frolik D; Caduff R; Varga Z Histopathology; 2001 Nov; 39(5):503-13. PubMed ID: 11737309 [TBL] [Abstract][Full Text] [Related]
20. Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast. Concha A; Ruiz-Cabello F; Cabrera T; Nogales F; Collado A; Garrido F Eur J Immunogenet; 1995 Aug; 22(4):299-310. PubMed ID: 7495782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]